An Open Label Study of AMG 706 in Subjects with Advanced Gastrointestinal Stromal Tumors (GISTs) who Developed Progressive Disease or Relapsed While on Imatinib Mesylate
|Effective start/end date
|9/15/04 → 12/31/09
- AMGEN INC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.